Only including simple chromosomal abnormalities with 2 or less changes, but not those with complex abnormalities with 3 or more aberrations.
Supplementary Table 4
Supplementary Kaplan-Meier survival curves for overall survival and disease-free survival in total 363 AML patients stratified by the status of SF3B1 mutation (A and B), SRSF2 mutation (C and D) and U2AF1 mutation (E and F), respectively.
Supplementary Figure 2
Sequential analyses ofU2AF1, IDH2 and NRAS mutations in patient 22.
The amplitude of the mutant sequence of U2AF1 was much lower at complete remission (CR) compared to that at diagnosis and relapse. Arrows indicated the
